Antibody Engineering |
Hong, Hyo-Jeong
(Antibody Engineering Laboratory, Research Institute of Bioscience and Biotechnology, Daejon, Aprogen, Inc., Bio Venture center, Research Institute of Bioscience and Biotechnology, Daejeon)
Kim, Sun-Taek (Aprogen, Inc., Bio Venture center, Research Institute of Bioscience and Biotechnology, Daejeon) |
1 |
Protein engineering of antibody binding sites: recovery of specific activity in an anti-digoxin single-chain Fv analogue produced in Escherichia coli
/
DOI ScienceOn |
2 |
An antibody single-domain phage display library of a native heavy chain variable region: isolation of functional single-domain VH molecules with a unique interface
/
DOI ScienceOn |
3 |
Engineering antibodies for therapy
/
DOI |
4 |
Expression of antibody Fab domains on bacteriophage surfaces. Potential use for antibody selection
/
|
5 |
Importance of the linker in expression of single-chain Fv antibody fragments: optimisation of peptide sequence using phage display technology
/
DOI ScienceOn |
6 |
Replacing the complementarity-determining regions in a human antibody with those from a mouse
/
DOI ScienceOn |
7 |
By-passing selection: direct screening for antibody-antigen interactions using protein arrays
/
DOI |
8 |
Optimizing the stability of single-chain proteins by linker length and composition mutagenesis
/
DOI ScienceOn |
9 |
Exploiting antibody-based technologies to manage environmental pollution
/
DOI ScienceOn |
10 |
Antibody engineering
/
DOI ScienceOn |
11 |
The immunogenicity of the 7E3 murine monoclonal Fab antibody fragment variable region is dramatically reduced in humans by substitution of human for murine constant regions
/
DOI ScienceOn |
12 |
Efficient tumor targeting by singledomain antibody fragments of camels
/
DOI ScienceOn |
13 |
/
|
14 |
Towards proteome-wide production of monoclonal antibody by phage display
/
DOI ScienceOn |
15 |
Phage antibodies: filamentous phage displaying antibody variable domains
/
DOI ScienceOn |
16 |
Fab assembly and enrichment in a monovalent phage display system
/
DOI ScienceOn |
17 |
Antibody arrays for high-throughput screening of antibody-antigen interactions
/
DOI ScienceOn |
18 |
High-avidity human IgG kappa monoclonal antibodies from a novel strain of minilocus transgenic mice
/
DOI ScienceOn |
19 |
Production of human antibody repertoires in transgenic mice
/
DOI ScienceOn |
20 |
High level Escherichia coli expression and production of a bivalent humanized antibody fragment
/
DOI ScienceOn |
21 |
Fully synthetic human combinatorial antibody libraries (HuCAL) based on modular consensus frameworks and CDRs randomized with trinucleotides
/
|
22 |
Phage diabody repertoires for selection of large numbers of bispecific antibody fragments
/
DOI ScienceOn |
23 |
Multi-subunit proteins on the surface of filamentous phage: methodologies for displaying antibody (Fab) heavy and light chains
/
DOI ScienceOn |
24 |
Picomolar affinity antibodies from a fully synthetic naive library selected and evolved by ribosome display
/
DOI ScienceOn |
25 |
Conformational stability, folding, and ligand-binding affinity of single-chain Fv immunoglobulin fragments expressed in Escherichia coli
/
DOI ScienceOn |
26 |
Naturally occurring antibodies devoid of light chains
/
DOI ScienceOn |
27 |
A single-domain antibody fragment in complex with RNase A: Non-canonical loop structures and nanomolar affinity using two CDR loops
/
DOI ScienceOn |
28 |
Clinical issues in antibody design
/
DOI ScienceOn |
29 |
Crystal structure of a camel single-domain VH antibody fragment in complex with lysozyme
/
DOI ScienceOn |
30 |
The use of recombinant antibodies in proteomics
/
DOI ScienceOn |
31 |
Reshaping human antibodies for therapy
/
DOI ScienceOn |